Literature DB >> 29698628

Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation.

Katerina Pyrillou1, Aikaterini-Dimitra Chairakaki2, Constantin Tamvakopoulos3, Evangelos Andreakos4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29698628     DOI： 10.1016/j.jaci.2018.04.004

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  11 in total

Review 1.  Specialized pro-resolving mediator network: an update on production and actions.

Authors:  Nan Chiang; Charles N Serhan
Journal:  Essays Biochem       Date:  2020-09-23       Impact factor: 8.000

Review 2.  Quenching the fires: Pro-resolving mediators, air pollution, and smoking.

Authors:  Thomas H Thatcher; Collynn F Woeller; Claire E McCarthy; Patricia J Sime
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

3.  Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation.

Authors:  Nan Chiang; Xavier de la Rosa; Stephania Libreros; Hui Pan; Jonathan M Dreyfuss; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

Review 4.  Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial.

Authors:  Hildur Arnardottir; Sven-Christian Pawelzik; Ulf Öhlund Wistbacka; Gonzalo Artiach; Robin Hofmann; Ingalill Reinholdsson; Frieder Braunschweig; Per Tornvall; Dorota Religa; Magnus Bäck
Journal:  Front Physiol       Date:  2021-01-11       Impact factor: 4.566

Review 5.  COVID-19 and cancer: start the resolution!

Authors:  Chantal Barksdale; Franciele C Kipper; Selvakumar Subbian; Charles N Serhan; Dipak Panigrahy; Shreya Tripathy
Journal:  Cancer Metastasis Rev       Date:  2022-03       Impact factor: 9.237

6.  Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response.

Authors:  James Turnbull; Rakesh R Jha; Catherine A Ortori; Eleanor Lunt; Patrick J Tighe; William L Irving; Sameer A Gohir; Dong-Hyun Kim; Ana M Valdes; Alexander W Tarr; David A Barrett; Victoria Chapman
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

Review 7.  Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development.

Authors:  Kabir Ahluwalia; Brandon Ebright; Kingsley Chow; Priyal Dave; Andrew Mead; Roy Poblete; Stan G Louie; Isaac Asante
Journal:  Metabolites       Date:  2022-04-07

Review 8.  Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease.

Authors:  Jesmond Dalli; Esteban Alberto Gomez; Charlotte Camille Jouvene
Journal:  Biomolecules       Date:  2022-02-23

9.  Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19.

Authors:  Evangelos Andreakos; Maria Papadaki; Charles N Serhan
Journal:  Allergy       Date:  2021-03       Impact factor: 14.710

10.  Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19.

Authors:  Issa Beegun; Charlotte Camille Jouvene; Duco Steven Koenis; Gabriel Amador Aguirre; Patricia Regina Souza; Maria Gonzalez-Nunez; Lucy Ly; Kimberly Pistorius; Hemant M Kocher; William Ricketts; Gavin Thomas; Mauro Perretti; Ghassan Alusi; Paul Pfeffer; Jesmond Dalli
Journal:  Circ Res       Date:  2021-07-09       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.